MedTrace Logo

Safety and Efficacy of Evolocumab in Ischemic Stroke

NCT05697185 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-01-25

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effect of evolocumab in combination with statin therapy (atorvastatin) in acute ischemic stroke (AIS).

Conditions

  • Ischemic Stroke, Acute

Interventions

DRUG

Evolocumab

Patients were randomly assigned of the ratio of 1:1 using a computer-generated random number and divided into two treatment groups: the statin alone therapy and the evolocumab plus statin therapy.

Sponsors & Collaborators

  • Second Affiliated Hospital of Guangxi Medical University

    lead OTHER

Principal Investigators

  • Junli Liang, PhD · The Second Affiliated Hospital of Guangxi Medical University, Nanning, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2024-02-01
Completion
2024-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05697185 on ClinicalTrials.gov